A study to find how safe different doses of LFD-200 are and how it works in both healthy people and people with moderate to severe rheumatoid arthritis

What you commit to

• Study type: Interventional · Phase 1
• Planned participants: 40
• 2 sites in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

AI-kivonat: who the study is looking for

Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for healthy adults and adults with moderate to severe rheumatoid arthritis. It tests how safe different doses of LFD-200 are and how it works.

Age

18 years or older

Sex

All sexes can join

Disease stage

Moderate to severe rheumatoid arthritis (healthy people can also join)

Read by machine on 9 Nov 2026.

Sites (2)

Sites in registry order. Save your city in your profile to sort them by distance.

Are you the coordinator? Confirm the details